The restructuring industry held its proverbial breath following the Supreme Court’s decision in Harrington v. Purdue Pharma L.P., which invalidated the nonconsensual third-party release in the debtors’ plan. While various...more
It has been approximately two months since the highly anticipated Supreme Court decision in Harrington v. Purdue Pharma L.P., and it is already making a significant impact in bankruptcies around the country. In September...more
8/30/2024
/ Bankruptcy Court ,
Bankruptcy Trustees ,
Chapter 11 ,
Commercial Bankruptcy ,
Creditors ,
Debtors ,
Harrington v Purdue Pharma L P ,
Mass Tort Litigation ,
Opioid ,
Opt-In ,
Opt-Outs ,
Purdue Pharma ,
Reorganizations ,
SCOTUS ,
Third-Party
As previously discussed and anticipated in prior blog posts, the United States Supreme Court’s decision in Siegel v. Fitzgerald, 596 U.S. 464, 142 S.Ct. 1770, 213 L.Ed.2d 39 (2022), which struck down as unconstitutional the...more
6/27/2024
/ Bankruptcy Court ,
Bankruptcy Trustees ,
Chapter 11 ,
Creditors ,
Debtors ,
Disparate Treatment ,
Fees ,
Overpayment ,
SCOTUS ,
Siegel v Fitzgerald 596 US ,
Siegel v. Fitzgerald ,
Trustees
Kaiser Gypsum Company Inc. and Hanson Permanente Cement, Inc. (collectively, the “Debtors”), manufacturers of asbestos-containing cement products, filed for chapter 11 bankruptcy on September 30, 2016 (“Petition Date”) in the...more